News

Filter

Current filters:

CiplaPharmaceutical

1 to 9 of 24 results

Meda and Cipla sue Apotex to enforce Dymista patents

Meda and Cipla sue Apotex to enforce Dymista patents

04-12-2014

Swedish pharma company Meda Pharmaceuticals and Indian drugmaker Cipla today have sued Canada-headquartered…

ApotexCiplaDymistaLegalMedaPharmaceuticalRespiratory and PulmonaryUSA

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

Medicines for Malaria Venture signs collaboration with Cipla and Strides Arcolab for rectal artesunate

27-11-2014

The Medicines for Malaria Venture has signed collaboration agreements with Cipla and Strides Arcolab,…

Antibiotics and Infectious diseasesCiplaIndiaPharmaceuticalResearchStrides Arcolab

India’s Cipla calls for revocation of Novartis’ Onbrez patents

01-11-2014

Indian drugmaker Cipla has asked the government to revoke five patents that Swiss pharma major Novartis…

CiplaIndiaMarkets & MarketingNovartisOnbrezPatentsPharmaceuticalRespiratory and PulmonaryUnibrez

Bristol-Myers resolves Sustiva patent litigation in USA

Bristol-Myers resolves Sustiva patent litigation in USA

08-10-2014

US pharma major Bristol-Myers Squibb has successfully resolved all outstanding US patent litigation relating…

Anti-viralsAtriplaBristol-Myers SquibbCiplaLegalMerck & CoPatentsPharmaceuticalSustivaUSA

Cipla in deal to set up a manufacturing unit in Iran

Cipla in deal to set up a manufacturing unit in Iran

06-10-2014

Indian drug major Cipla has signed an agreement with its Iranian distributor for setting up a manufacturing…

CiplaIranMergers & AcquisitionsPharmaceuticalProduction

Cipla invests $1.5 million for 14.6% stake in USA’s Chase Pharma

14-05-2014

Indian drugmaker Cipla has said it will acquire a 14.6% stake in US-based Chase Pharmaceuticals for $1.5…

Chase PharmaceuticalsCiplaCPC 201Mergers & AcquisitionsNeurologicalPharmaceutical

Indian govt to penalize drugmakers for overcharging

Indian govt to penalize drugmakers for overcharging

06-05-2014

In a major crackdown, India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA)…

CiplaFinancialGlaxoSmithKlineIndiaPharmaceuticalPricing

Merck & Co partners with Cipla for Indian marketing of raltegravir

Merck & Co partners with Cipla for Indian marketing of raltegravir

21-02-2014

US pharma giant Merck & Co, known as MSD outside North America, has announced the formation of an India-specific…

Anti-viralsAsia-PacificCiplaIndiaIsentressMarkets & MarketingMerck & CoPharmaceuticalRaltegravir Tablets

1 to 9 of 24 results

Back to top